3-[(4-Methylpiperidin-1-yl)methyl]phenol | 90287-67-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 3-[(4-Methylpiperidin-1-yl)methyl]phenol
• CAS: 90287-67-5
• 化学式: C₁₃H₁₉NO
• 分子量: 205.3
• InChiKey: WLBPKMYCQDQFLG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  23.5
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• Thienopyrimidines and Thiazolopyrimidines for Use in Medicine
  申请人：Bower Fairfield Justin

  公开号：US20070244133A1

  公开（公告）日：2007-10-18

  The use of a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein X 1 , X 2 , X 3 , X 4 , R a , p, R 1 , Z, Y, R 2 , R 3 and R 4 are as defined in the specification, in the preparation of a medicament for the treatment of C—C chemokine mediated conditions, such as inflammatory disease. Certain compounds of formula (I) are novel and these, together with their preparation are also described and claimed.

  使用公式（I）或其药学上可接受的盐或溶剂，其中X1，X2，X3，X4，Ra，p，R1，Z，Y，R2，R3和R4如规范所定义，在制备治疗C-C趋化因子介导疾病（如炎症性疾病）的药物中使用。公式（I）的某些化合物是新颖的，这些化合物以及它们的制备也被描述和声明。
• Agents and crystals for improving excretory potency of urinary bladder
  申请人：Ishihara Yuji

  公开号：US20090264467A1

  公开（公告）日：2009-10-22

  Agents for improving potency of the urinary bladder which comprise an amine compound of non-carbamate-type having an acetylcholinesterase-inhibiting action. Particularly, crystals of a tricyclic, condensed, heterocyclic derivative are provided, which possess an excellent action to inhibit acetylcholinesterase and an action to improve the excretory potency of the urinary bladder. As an example, crystals of 8-[3-[1-[(3-fluorophenyl)-methyl]-4-piperidinyl]-1-oxopropyl]-1,2,5,6-tetrahydro-4H-pyrrolo[3,2,1-ij]quinolin-4-one or a salt thereof and pharmaceutical compositions containing them are disclosed.

  提高膀胱功能的药物，包括一种非卡巴酯类胺化合物，具有乙酰胆碱酯酶抑制作用。具体而言，提供了一种三环、紧缩、杂环衍生物的晶体，其具有优异的抑制乙酰胆碱酯酶的作用和改善膀胱排泄功能的作用。例如，披露了8-[3-[1-[(3-氟苯基)-甲基]-4-哌啶基]-1-氧代丙基]-1,2,5,6-四氢-4H-吡咯并[3,2,1-ij]喹啉-4-酮或其盐以及含有它们的制药组合物。
• 3,4-Disubstituted-1,2,5-oxadiazoles having histamine H2-receptor antagonist activity
  申请人：Bristol-Myers Squibb Company

  公开号：EP0150073A1

  公开（公告）日：1985-07-31

  Histamine H2-antagonists of the formula: wherein m is an integer of from 0 to 2 inciusive; n is an integer of from 2 to 5 inclusive; Z is oxvaen. sulfur or methviene: and A is in which R1 is hydrogen, (lower)alkyl, or (lower) alkoxy, and R2 is in which q is an integer of from 1 to 4 inclusive, and R3 and R4 each are independently, (lower) alkyl, (lower)alkoxy (lower) alkyl in which the (lower) alkoxy moiety is at least two carbon atoms removed from the nitrogen atom, cyclo (lower) alkyl, or phenyl (lower) alkyl; provided that R3 and R4 may not both be cyclo (lower) alkyl; or R3 and R4, taken together with the nitrogen atom to which they are attached, may be pyrrolidino, methylpyrrolidino, dimethylpyrrolidino, morpholino, thiomorpholino, piperidino, methylpiperidino, dimethylpiperidino, N-methylpiperazino, 1,2,3,6-tetrahydropyridyt, homopiperidino, heptamethyleneimino, octamethyleneimino, or 3-azabicyclo-[3.2.2]non-3-yl; and nontoxic, pharmaceutically acceptable salts, hydrates, solvates and N-oxides thereof.

  式中的组胺 H2- 拮抗剂： 式中 m 是 0 至 2（含）的整数； n 是 2 至 5（包括 5）的整数； Z 是氧、硫或甲硫醚；以及 A 是 其中 R1 是氢、（低级）烷基或（低级）烷氧基，R2 是 其中 q 是 1 至 4（包括 4）的整数，R3 和 R4 各自独立地是（低级）烷基、（低级）烷氧基（低级）烷基（其中（低级）烷氧基分子从氮原子移除至少两个碳原子）、环（低级）烷基或苯基（低级）烷基；但 R3 和 R4 不能都是环（低级）烷基；或 R3 和 R4 连同它们所连接的氮原子可以是吡咯烷基、甲基吡咯烷基、二甲基吡咯烷基、吗啉基、硫代吗啉基、哌啶基、甲基哌啶基、二甲基哌啶基、N-甲基哌嗪基、1,2,3,6-四氢吡啶基、均哌啶基、七亚甲基亚氨基、八亚甲基亚氨基或 3-氮杂双环-[3.2.2]壬-3-基；以及它们的无毒、药学上可接受的盐、水合物、溶剂和 N-氧化物。
• 2-Substituted amino-4(1H)-pyrimidone derivatives, their production, and medical compositions containing them
  申请人：YAMANOUCHI PHARMACEUTICAL CO. LTD.

  公开号：EP0186275A2

  公开（公告）日：1986-07-02

  A 2-substituted amino-4 (1H)-pyrimidone derivative shown by the general formula wherein R' and R2, which may be the same or different, each represents a hydrogen atom or a lower alkyl group; R3 represents an alkyl group, an alkenyl group, an alkynyl group, a halogen-substituted alkyl group, a halogen-substituted alkenyl group, a halogen-substituted alkynyl group, or an alkyl group interrupted by an oxygen atom or a sulfur atom; R4 represents a hydrogen atom or a lower alkyl group; m is an integer of 1 or 3 and n is an integer of 2 or 4 (with said R4 being a lower alkyl group when R' and R2 are hydrogen atoms, R3 is an alkyl group, m is 2 and n is 3) or an acid addition salt thereof. The compounds of this invention have both histamine H2-receptor antagonist activity and gastric cytoprotective activity and are very useful as drugs for gastric diseases.

  通式如下的 2-取代氨基-4(1H)-嘧啶酮衍生物 其中 R'和 R2（可以相同或不同）各自代表氢原子或低级烷基；R3 代表烷基、烯基、炔基、卤素取代的烷基、卤素取代的烯基、卤素取代的炔基、或被氧原子或硫原子打断的烷基；R4 代表氢原子或低级烷基；m 为 1 或 3 的整数，n 为 2 或 4 的整数（当 R' 和 R2 为氢原子，R3 为烷基，m 为 2，n 为 3 时，所述 R4 为低级烷基）或其酸加成盐。 本发明的化合物同时具有组胺 H2 受体拮抗剂活性和胃细胞保护活性，作为治疗胃病的药物非常有用。
• US4507485A
  申请人：——

  公开号：US4507485A

  公开（公告）日：1985-03-26